glp-1 drug comparison Best Med #2: Receptor Agonists — vim Performance Medicine developed bundle cultivating targeted restoration across the Gut GLP-1 Supplements are lucrative scams
Description
10.1172/jci.insight.93091 [DOI] [PMC free article] [PubMed] 49.Folli F, La Rosa S, Finzi G, et al
doi:10.1007/s00125-002-0878-6 37
Pros: Generic versions are now available (as of 2025/2026), making it a more affordable option
The core mechanism difference: dual versus triple agonism Understanding why retatrutide outperforms Mounjaro requires understanding what the glucagon receptor actually does when activated alongside GLP-1 and GIP
By comparison, the STEP 1 trial for semaglutide reported 14.9% at 68 weeks, and SURMOUNT-1 for tirzepatide reported 20.9% at 72 weeks
